We are live on ! Find out more
XTNT icon

Xtant Medical Holdings

17 hedge funds and large institutions have $4.03M invested in Xtant Medical Holdings in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

6% less funds holding

Funds holding: 1817 (-1)

25% less capital invested

Capital invested by funds: $5.4M → $4.03M (-$1.37M)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change

XTNT Hedge Fund Activity: Q2 2016 in Review

17 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q2 2016, worth a combined $4.03M — down 25% from $5.4M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of XTNT and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.

The largest buyer was Goldman Capital Management, adding an estimated $277K. The largest seller was Millennium Management, exiting entirely with an estimated $60K sold.

  • 17 institutional investors held Xtant Medical Holdings (XTNT) as of Q2 2016, down from 18 in Q1 2016.
  • Funds reported $4.03M of Xtant Medical Holdings stock for Q2 2016, down 25% quarter-over-quarter.
  • 2 funds opened new Xtant Medical Holdings positions in Q2 2016 and 3 closed out, a net change of -1 holder.
  • The largest Xtant Medical Holdings buyer in Q2 2016 was Goldman Capital Management, an estimated $277K added.
  • The largest Xtant Medical Holdings seller in Q2 2016 was Millennium Management, an estimated $60K sold.

Based on aggregated 13F filings for Q2 2016.